Effect of infectious bursal agent on the response of chickens to Newcastle disease and Marek's disease vaccination
- PMID: 183651
Effect of infectious bursal agent on the response of chickens to Newcastle disease and Marek's disease vaccination
Abstract
White Leghorn chickens raised from one day old in an environment contaminated by the infectious bursal agent (IBA) had lower geometric mean titers (GMT) as measured by the hemagglutination-inhibition (HI) test to the Newcastle disease virus (NDV), than control Leghorns reared in an uncontaminated environment. Immunosuppression, defined as a reduction in GMT, was most pronounced at 35-56 days old for Leghorns vaccinated with NDV at 1 and 28 days or at 28 days. In a separate trial with broilers, immunosuppression was similar at 42-56 days old. This study also demonstrated that IBA infection in chickens increased susceptibility to Marek's disease (MD). The unvaccinated control chickens infected with IBA averaged 56.3% MD lesions, whereas unvaccinated controls not exposed to IBA averaged only 18.1% macroscopic lesions. It was also found that 20.7% of the HVT-vaccinated chickens exposed to IBA had gross MD lesions, whereas those HVT-vaccinated chickens reared in an environment free of IBA had 2.99% gross MD lesions.
Similar articles
-
Effects of infectious bursal disease on Marek's disease vaccination: suppression of antiviral immune response.Avian Dis. 1980 Oct-Dec;24(4):896-907. Avian Dis. 1980. PMID: 6268042
-
The immunodepressive effect of infectious bursal agent on vaccination against Newcastle disease.Res Vet Sci. 1977 Mar;22(2):222-4. Res Vet Sci. 1977. PMID: 193172
-
Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.Avian Dis. 1992 Oct-Dec;36(4):858-70. Avian Dis. 1992. PMID: 1485872
-
Prevention of Marek's disease: a review.Cancer Res. 1976 Feb;36(2 pt 2):696-700. Cancer Res. 1976. PMID: 766959 Review.
-
Clinical aspects of immunosuppression in poultry.Avian Dis. 2010 Mar;54(1):2-15. doi: 10.1637/8909-043009-Review.1. Avian Dis. 2010. PMID: 20408392 Review.
Cited by
-
Fusion protein strategy to increase expression and solubility of hypervariable region of VP2 protein of infectious bursal disease virus in Escherichia coli.Protein J. 2012 Oct;31(7):580-4. doi: 10.1007/s10930-012-9437-2. Protein J. 2012. PMID: 22865249
-
Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.Sci Rep. 2016 Dec 16;6:39263. doi: 10.1038/srep39263. Sci Rep. 2016. PMID: 27982090 Free PMC article.
-
Correlation of hematological changes and serum and monocyte inhibition with the early suppression of phytohemagglutinin stimulation of lymphocytes in experimental infectious bursal disease.Can J Comp Med. 1982 Apr;46(2):169-75. Can J Comp Med. 1982. PMID: 6284327 Free PMC article.
-
Combination of TLR2 and TLR3 agonists derepress infectious bursal disease virus vaccine-induced immunosuppression in the chicken.Sci Rep. 2019 Jun 3;9(1):8197. doi: 10.1038/s41598-019-44578-5. Sci Rep. 2019. PMID: 31160675 Free PMC article.
-
Effect of infectious bursal disease on natural killer cell activity and mitogenic response of chicken lymphoid cells: role of adherent cells in cellular immune suppression.Infect Immun. 1983 Nov;42(2):747-54. doi: 10.1128/iai.42.2.747-754.1983. Infect Immun. 1983. PMID: 6315586 Free PMC article.